外来血圧モニターの世界市場：2024年～2031年

概要

世界の外来血圧モニター市場は、2023年に12億米ドルに達し、2024年から2031年の予測期間中にCAGR 9.2%で成長し、2031年には24億3,000万米ドルに達すると予測されています。

外来血圧モニタリング（ABPM）は、患者が通常の日常生活を送りながら、24時間にわたって一定の間隔で血圧を測定する診断方法です。この方法では、昼夜を問わずさまざまな時間帯の変動を記録するため、従来の診察室での測定に比べて血圧変動をより正確に描写することができます。

外来血圧モニタリング（ABPM）装置は、腕または手首に装着するカフにリンクされた携帯型モニターで構成され、指定された間隔で自動的に膨張して血圧測定値を取得します。外来血圧モニタリングは、高血圧を評価し管理するための貴重で徹底した方法です。血圧変動に関する継続的でリアルタイムのデータを提供することで、診断精度が向上し、ヘルスケアプロバイダーは十分な情報に基づいた治療決定を下せるようになり、最終的に高血圧管理における患者の転帰改善につながります。

市場力学：

促進要因

高血圧有病率の上昇

世界の外来血圧モニター市場の需要は、複数の要因によって牽引されています。高血圧の有病率の増加は、外来血圧モニタリング（ABPM）市場を推進する重要な要因です。世界中で数百万人が罹患しており、高齢化によりリスクが高まっているため、信頼性の高い血圧モニタリング・ソリューションに対する需要が急増しています。技術の進歩、健康意識の高まり、政府による支援プログラムがABPM市場の需要をさらに高めています。

高血圧は、世界的に早期死亡の大きな要因となっています。非感染性疾患に関する国際目標の1つは、2010年から2030年の間に高血圧の有病率を33%減少させることです。2023年3月のWHOのデータによると、世界で30～79歳の成人12億8,000万人が高血圧に罹患していると推定され、その約3分の2は低・中所得国に居住しています。高血圧の成人の約46%は、自分の症状に気づいておらず、診断を受けて治療を受けているのは半数以下（42%）です。また、高血圧患者のうち、わずか21％しか高血圧をコントロールできていません。

さらに、業界の主要企業は、この外来血圧モニタリング（ABPM）市場の成長を促進するような技術的進歩や製品の発売を行っています。例えば、2022年10月、Biobeatは革新的なカフレス・モニタリング技術により、高血圧患者とヘルスケア提供者の双方にとって24時間外来血圧モニタリング（ABPM）体験に革命を起こしています。この進歩は、従来の血圧モニタリング方法に関連するいくつかの制限に対処するものです。

また、2021年5月には、ウェアラブル遠隔患者モニタリング技術で著名なBiobeatが、胸部に快適に装着できる連続的な外来血圧モニタリング（ABPM）用に特別に設計された新しいデバイスを発表しました。この先進的な胸部モニター装置により、ヘルスケア専門家は患者の血圧を継続的に追跡できるようになり、従来の臨床環境以外でのバイタルサインのモニタリング能力が大幅に向上します。

阻害要因

機器の高コスト、限られた償還政策、使用に伴う合併症などの要因が、外来血圧モニタリング（ABPM）市場の妨げになると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 高血圧の有病率の上昇
  • 抑制要因
    • デバイスの高コスト
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 製品タイプ別

• アームモニター
  • デジタルアームモニター
  • アネロイドアームモニター
  • 水銀アームモニター
• リストモニター（デジタルリストモニター）

第7章 操作タイプ別

• オートマチックモニター
• セミオートマチックモニター
• 手動式モニター

第8章 エンドユーザー別

• 病院および専門クリニック
• 在宅医療
• 外来手術センター（ASC）

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第11章 企業プロファイル

• Spacelabs Healthcare.
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• BOSCH+SOHN GmbH Co. KG.
• SunTech Medical, Inc.
• Schiller AG
• Baxter International Inc（Welch Allyn）
• BPL Medical Technologies
• A&D Company
• Microlife Corporation
• CONTEC MEDICAL SYSTEMS CO., LTD
• Vaso Corporation

第12章 付録

Overview

The global Ambulatory blood pressure monitors market reached US$ 1.20 billion in 2023 and is expected to reach US$ 2.43 billion by 2031 growing with a CAGR of 9.2% during the forecast period 2024-2031.

Ambulatory blood pressure monitoring (ABPM) is a diagnostic method that measures a patient's blood pressure at regular intervals over 24 hours while they carry out their usual daily activities. This approach offers a more precise depiction of blood pressure variations compared to conventional office measurements, as it records fluctuations at different times throughout the day and night.

Ambulatory blood pressure monitoring (ABPM) devices consist of a portable monitor linked to a cuff worn on the arm or wrist, which automatically inflates at designated intervals to capture blood pressure readings Ambulatory blood pressure monitoring is a valuable and thorough method for assessing and managing hypertension. Delivering continuous, real-time data on blood pressure variations, improves diagnostic precision and enables healthcare providers to make well-informed treatment decisions, ultimately leading to better patient outcomes in managing hypertension.

Market Dynamics: Drivers

Rising prevalence of hypertension

The demand for the global ambulatory blood pressure monitors market is driven by multiple factors. The increasing prevalence of hypertension is a key factor propelling the ambulatory blood pressure monitoring (ABPM) market. With millions of individuals affected worldwide and an aging population at greater risk, there is an urgent demand for reliable blood pressure monitoring solutions. Advances in technology, rising health awareness, and supportive government programs further demand for the ABPM market.

Hypertension is a significant contributor to premature mortality globally. One of the international goals for noncommunicable diseases is to achieve a 33% reduction in the prevalence of hypertension between 2010 and 2030. As per WHO data in March 2023, an estimated 1.28 billion adults aged 30 to 79 years worldwide suffer from hypertension, with approximately two-thirds residing in low- and middle-income countries. About 46% of adults with hypertension are unaware of their condition, and less than half (42%) have been diagnosed and treated. Only 21% of those with hypertension manage to keep it under control.

Moreover, key players in the industry have technological advancements and product launches that would drive this ambulatory blood pressure monitoring (ABPM) market growth. For instance, in October 2022, Biobeat is revolutionizing the 24-hour ambulatory blood pressure monitoring (ABPM) experience for both hypertension patients and healthcare providers through its innovative cuffless monitoring technology. This advancement addresses several limitations associated with traditional blood pressure monitoring methods.

Also, in May 2021, Biobeat, a prominent name in wearable remote patient monitoring technologies, has recently unveiled a new device specifically designed for continuous ambulatory blood pressure monitoring (ABPM) that can be worn comfortably on the chest. This advanced chest-monitoring device allows healthcare professionals to continuously track patients' blood pressure, significantly improving the ability to monitor vital signs outside conventional clinical environments.

Restraints

Factors such as the high costs of devices, limited reimbursement policies, and complications associated with use are expected to hamper the ambulatory blood pressure monitoring (ABPM) market.

Segment Analysis

The global ambulatory blood pressure monitors market is segmented based on product type, operation type, end-user, and region.

The arm monitors segment accounted for approximately 73.2% of the global ambulatory blood pressure monitors market share

The arm monitors segment is expected to hold the largest market share over the forecast period. Arm monitors are widely regarded as more accurate than wrist monitors for measuring blood pressure. They use a standard cuff that wraps around the upper arm, which is the recommended site for obtaining reliable readings. This level of accuracy makes them the preferred option for clinicians who need precise data for diagnosis and treatment.

Additionally, arm ambulatory blood pressure monitoring (ABPM) devices have been extensively utilized in clinical settings for many years. Their established presence in hospitals and clinics lends credibility to their use among healthcare professionals, leading to a continued preference for these devices over newer wrist models. Advancements in ambulatory blood pressure monitoring (ABPM) technology have greatly changed the field of blood pressure measurement, resulting in the creation of more compact and user-friendly devices, such as wrist and arm monitors.

Moreover, key players in the industry introduce innovative products and approvals that would propel this ambulatory blood pressure monitoring (ABPM) market growth. For instance, one of the major players SunTech Medical launched the Oscar 2 ambulatory blood pressure monitor is esteemed as the leading device in 24-hour ambulatory blood pressure monitoring (ABPM).

It is designed to deliver essential diagnostic data that traditional in-clinic and home blood pressure monitors often miss, making it an invaluable resource for healthcare professionals. The device emphasizes patient comfort through its patented Orbit ABPM cuff, which is designed with a soft and flexible material that fits snugly around the arm. This design allows patients to wear the monitor for long durations without discomfort, encouraging greater compliance with monitoring protocols.

Similarly, The BPro EVO from HealthSTATS International is a third-generation ambulatory blood pressure monitor (ABPM) that integrates several advanced features aimed at improving patient monitoring and enhancing data accuracy.

Also, in October 2024, Huawei introduced the Watch D2 a smartwatch that sets itself apart with its sophisticated health monitoring features, particularly through its Ambulatory Blood Pressure Monitoring (ABPM) capability. This technology allows users to continuously monitor their blood pressure around the clock, providing critical insights into their cardiovascular health.

Geographical Analysis

North America accounted for approximately 43.2% of the global ambulatory blood pressure monitors market share

North America region is expected to hold the largest market share over the forecast period. The high prevalence of hypertension in North America significantly influences the ambulatory blood pressure monitors (ABPM) market. Hypertension, commonly referred to as high blood pressure, elevates the risk of heart disease and stroke, which are among the leading causes of death in the United States.

Moreover, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, government initiatives & regulatory support, technological advancements, & investments, and product launches would propel this ambulatory blood pressure monitoring (ABPM) market growth. For instance, in August 2022, CardiAI Inc. officially launched its new 24-hour ambulatory blood pressure monitoring system, named BPAro. This device is compact and portable, manufactured in Germany, and designed for individuals to monitor their blood pressure. Utilizing Bluetooth technology, BPAro wirelessly collects data, which is then securely uploaded to a cloud database for analysis.

Market Segmentation

By Product Type

• Arm Monitors
  • Digital Arm Monitors
  • Aneroid Arm Monitors
  • Mercury Arm Monitors
• Wrist Monitors (Digital Wrist Monitors)

By Operation Type

• Automatic Monitors
• Semi-Automatic Monitors
• Manual Monitors

By End-User

• Hospitals & Specialty Clinics
• Homecare Settings
• Ambulatory Surgical Centers (ASCs)

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • The rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the ambulatory blood pressure monitors market include Spacelabs Healthcare., BOSCH + SOHN GmbH Co. KG., SunTech Medical, Inc., Schiller AG, Baxter International Inc. (Welch Allyn, BPL Medical Technologies, A&D Company, Microlife Corporation, CONTEC MEDICAL SYSTEMS CO., LTD, and Vaso Corporation among others.

Key Developments

• In March 2024, seca Screen 300 ABPM was introduced as a state-of-the-art ambulatory blood pressure monitor (ABPM), recognized for its cutting-edge features and significant validation. It is distinguished as the first ABPM device in the world to achieve successful validation under the European Society of Hypertension International Protocol (ESH-IP) 2010 standards.

Why Purchase the Report?

• To visualize the global ambulatory blood pressure monitors market segmentation based on product type, operation type, end-user, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points on the ambulatory blood pressure monitors market in all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in excel consisting of key products of all the major players.

The global ambulatory blood pressure monitors market report would provide approximately 62 tables, 51 figures, and 183 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Operation Type
• 3.3. Snippet by End-User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising Prevalence of Hypertension
  • 4.1.2. Restraints
    • 4.1.2.1. High Cost of Devices
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Arm Monitors*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.2.3. Digital Arm Monitors
  • 6.2.4. Aneroid Arm Monitors
  • 6.2.5. Mercury Arm Monitors
• 6.3. Wrist Monitors (Digital Wrist Monitors)

7. By Operation Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Type
  • 7.1.2. Market Attractiveness Index, By Operation Type
• 7.2. Automatic Monitors *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Semi-Automatic Monitors
• 7.4. Manual Monitors

8. By End-User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.1.2. Market Attractiveness Index, By End-User
• 8.2. Hospitals & Specialty Clinics *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Homecare Settings
• 8.4. Ambulatory Surgical Centers (ASCs)

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Type
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Type
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Spain
    • 9.3.6.5. Italy
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Type
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Type
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Type
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. Spacelabs Healthcare. *
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. BOSCH + SOHN GmbH Co. KG.
• 11.3. SunTech Medical, Inc.
• 11.4. Schiller AG
• 11.5. Baxter International Inc (Welch Allyn)
• 11.6. BPL Medical Technologies
• 11.7. A&D Company
• 11.8. Microlife Corporation
• 11.9. CONTEC MEDICAL SYSTEMS CO., LTD
• 11.10. Vaso Corporation

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us